First Tuberculosis Drug in 40 Years Has Otsuka Cautious
This article is for subscribers only.
Otsuka Holdings Co. executives are drawing up plans to ensure their new drug isn’t a quick hit.
The Japanese company says it’s proceeding with caution now that the medicine, which may be the first new tuberculosis treatment in four decades, passed a key test.